World Journal of Stem Cells

World Journal of Stem Cells (WJSC) is an international peer-reviewed open-access journal covering stem cell biology and regenerative medicine, published monthly by Baishideng Publishing Group in Pleasanton, California, launched on 31 December 2009, with a 2025 Journal Impact Factor of 4.9《世界干细胞杂志》（WJSC）是国际同行评审开放获取期刊，报道干细胞生物学与再生医学，由位于加州普莱森顿的（Baishideng Publishing Group）按月出版，2009 年 12 月 31 日创刊，2025 年影响因子为 4.9。

Scope

• The journal covers embryonic, germline, tissue-specific and adult stem cells, together with mesenchymal stromal cells and induced pluripotent stem cells期刊覆盖胚胎干细胞、生殖系干细胞、组织特异性干细胞与成体干细胞，以及间充质基质细胞和诱导多能干细胞。
• Embryoid bodies, embryonal carcinoma stem cells, hemangioblasts, hematopoietic stem cells and lymphoid or myeloid progenitors are all within scope胚状体、胚胎癌干细胞、血管母细胞、造血干细胞以及淋系或髓系祖细胞均在收稿范围之内。
• Cardiac, skeletal and smooth muscle myoblasts, neural stem cells, neoplastic stem cells, side-population cells and totipotent stem cells are also covered心肌、骨骼肌与平滑肌成肌细胞、神经干细胞、肿瘤干细胞、侧群细胞与全能干细胞同样在列。
• It publishes clinical, translational and basic research, including studies that apply artificial intelligence to stem cell science刊物发表临床、转化与基础研究，包括将人工智能应用于干细胞科学的研究。
• The stem cell niche, stem cell genomics and proteomics, and techniques for clinical trials are recurring subjects干细胞微环境、干细胞基因组学与蛋白质组学，以及临床试验相关技术是常见主题。
• Article types include basic study, clinical study, case report, editorial, review, minireview, systematic review, meta-analysis, guidelines and correspondence文章类型包括基础研究、临床研究、病例报告、社论、综述、小综述、系统评价、荟萃分析、指南与通讯。
• The journal is aimed at clinicians and basic scientists working on regenerative medicine and cell-based therapy该刊面向从事再生医学与细胞治疗工作的临床医生和基础科学家。

History

• It was launched on 31 December 2009 by Baishideng Publishing Group, and a founding editorial by Lian-Sheng Ma set out the journal's purpose该刊由（Baishideng Publishing Group）于 2009 年 12 月 31 日推出，（Lian-Sheng Ma）撰写的创刊社论阐明了办刊宗旨。^[1]
• The journal was online-only from the start, registered under ISSN 1948-0210 and using the DOI prefix 10.4252期刊自创办起即为纯在线出版，注册刊号为 1948-0210，采用（DOI）前缀 10.4252。
• It has appeared monthly since launch, publishing twelve issues a year under continuous volume numbering自创刊以来按月出版，每年 12 期，卷号连续编排。
• Its publisher, Baishideng Publishing Group, was founded in 1993, is headquartered in California and runs an editorial office in Beijing其出版方（Baishideng Publishing Group）成立于 1993 年，总部位于加州，并在北京设有编辑部。
• The journal is fully open access and charges article processing charges, with content released under an open licence该刊为完全开放获取，收取文章处理费，内容以开放许可发布。
• The 2025 Journal Impact Factor is 4.9, compared with 3.6 in 2024, 5.247 in 2022 and 5.326 in 20212025 年影响因子为 4.9，2024 年为 3.6，2022 年为 5.247，2021 年为 5.326。
• It is indexed in Science Citation Index Expanded, PubMed, PubMed Central, Scopus and BIOSIS Previews该刊被（Science Citation Index Expanded）、（PubMed）、（PubMed Central）、（Scopus）与（BIOSIS Previews）收录。

Editors

• The Editor-in-Chief is Shengwen Calvin Li, a professor at the Children's Hospital of Orange County Research Institute and the University of California, Irvine现任主编为（Shengwen Calvin Li），他是（Children's Hospital of Orange County Research Institute）与（University of California Irvine）的教授。
• His research spans neuroscience and stem cell biology, and he leads the journal's editorial direction其研究涵盖神经科学与干细胞生物学，负责把握期刊的编辑方向。
• All submissions undergo single-blind review by at least two independent reviewers所有投稿均经至少两位独立审稿人进行单盲评审。
• Official metrics report a mean peer review time of 25 days, 46 days from submission to first decision and an acceptance rate of 48.7%官方数据显示，平均审稿周期为 25 天，从投稿到首次决定为 46 天，录用率为 48.7%。
• The journal publishes in fixed columns, and each article carries a provenance and peer-review label such as unsolicited and externally reviewed期刊按固定栏目出版，每篇文章都标注来源与评审属性，例如非邀约稿件、外部评审。
• Peer-review reports are graded for scientific quality and published with the article, a practice distinctive to Baishideng journals评审报告按科学质量分级并随文发表，这是（Baishideng）系列期刊的特色做法。
• Earlier editors include Oscar Kuang-Sheng Lee of Taipei Veterans General Hospital and Carlo Ventura, who served as co-editor-in-chief历任主编包括（Taipei Veterans General Hospital）的（Oscar Kuang-Sheng Lee），以及曾担任共同主编的（Carlo Ventura）。